Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 124 The United Laboratories International Holdings Limited Annual Report 2022 30. DEFERRED TAXATION (Continued) The Group’s unrecognised deductible temporary differences are as follows: 2022 2021 RMB’000 RMB’000 Tax loss carry forwards 561,518 503,322 During the years ended 31 December 2022 and 2021, no tax loss was expired. Included in unrecognised tax losses are losses of RMB7,898,000 (2021: RMB16,664,000) that will expire within five years, all other losses may be carried forward indefinitely. No deferred tax asset in respect of tax losses has been recognised because the amount of future taxable profit that will be available to realise such assets is uncertain. The unused tax losses will be expired as follows: 2022 2021 RMB’000 RMB’000 2022 – 4,681 2023 6,924 11,009 2024 974 974 7,898 16,664